Microbe 2016 Disclosures Listed by Session Session Title Disclosures Novel Insights Regarding the Microbiome and Pregnancy (Organized in Cooperation with the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG)) K. Aagaard, None. The Science of Learning L. R. Aaronson, None. Clinical Microbiology Board Review Course A. Abbott, None. RNA Modulation and Cellular Signals in Antimicrobial Resistance N. Abdali, None. H.I. Zgurskaya, None. Parasitology and Anti-parasitic Agents A. Abebe, None. H. Asrat, None. G. Ayana, None. Emerging Infections in HSCT: Limited Evidence (Organized in Cooperation with the European Society of Clinical Microbiology and Infectious Diseases) A. Abudayyeh, None. T. Miller-Roll, None. W. Na'amnih, None. D. Cohen, None. Y. Carmeli, Clostridium difficile Epidemiology and Control None. A. Adler, None. Epidemiology and Control of Nosocomial MDRO A. Adler, None. R. Glick,None. Y. Carmeli, None. Decoding Contamination: Addressing Contamination in the Laboratory, the Hospital and the World E. Afshinnekoo, None. S. Tripathi, None. D. Levin, None. Q. Feng, None. X. Li, None. M. Jacob, None. P. Donover, None. M. Reichman, None. A. Clark, None. A. Agarwal, Clinical Mycology None. Primer on Transplantation J. M. Aguado, None. The Resistance Network: Interplay between Environmental, Community and Nosocomial Superbugs (Joint ASM-FEMS Symposium) M. Aires-de-Sousa, None. Antimicrobial Stewardship II R.L. Akins, Investigator; Merck, Theravance Biopharma. M.D. Smith, None. Emerging Infections in HSCT: Limited Evidence (Organized in Cooperation with the European Society of Clinical Microbiology and Infectious Diseases) M. Akova, None. Encephalitis: What Is New? (Supported Jointly with the Société de Pathologie Infectieuse de Langue Française (SPILF)) A. Aksamit, None. Making an Impact: Utilization and Outcomes in the Microbiology Lab K. Alby, None. Making an Impact: Utilization and Outcomes in the Microbiology Lab K. Alby, None. Novel Strategies to Help Antibiotics to Play their Role S. Ali, None. R.K. Poole, None. Next-Generation Sequencing Applied to Clinical Practice and Pathogen Discovery M. W. Allard, None. Prevention and Treatment of Infection in the lmmunocompromised Child & Adolescent U. D. Allen, None. Foundations to Frontiers: The Molecular Revolution S. Altschul, None. More Trouble from Ticks in 2016 G. Alvarez-Hernandez, None. P. G. Ambrose, Consultant: Arsanis, Contrafect, Merck, Kalidex, Meiji, PTC, Roche, Spero, Theravance, Tetraphase, VenatoRx, Zavante, Institute for Clinical Pharmacodynamics, Cempra, Tetraphase, Spero, Paratek, Venato, UFL, Debiopharm, Wockhardt, Contrafect, Medicines Co., Merck, GSK, 3V Antimicrobial Breakpoints: Time for a Single CAST? Biosciences, Arsanis, Nabriva. Investigator. USCAST, Zavante Therapeutics. Microbe 2016 Disclosures Listed by Session P. G. Ambrose, Consultant: Arsanis, Contrafect, Merck, Kalidex, Meiji, PTC, Roche, Spero, Theravance, Tetraphase, VenatoRx, Zavante, Institute for Clinical Pharmacodynamics, Cempra, Tetraphase, Spero, Paratek, Venato, UFL, Debiopharm, Wockhardt, Contrafect, Medicines Co., Merck, GSK, 3V Biosciences, Arsanis, Nabriva. Investigator. USCAST, Zavante Therapeutics. J. McCauley: Employee; ICPD. C.M. Rubino: Employee; ICPD. K. Shareholder Innovations and Challenges in Pharmacokinetics/Pharmacodynamics (excluding diversitied mutual funds). S.M. Bhavnani: Employee; ICPD. (PK/PD) Shareholder (excluding diversitied mutual funds); ICPD. Novel Strategies to Help Antibiotics to Play their Role R. Amin, None. Front-end Automation in the Clinical Microbiology Laboratory N. Anderson, None. A. McMullen, None. R. Jennemann, None. Interplay between Antimicrobial Resistance and Bacterial Persistence D. I. Andersson, None. Measurement and Modeling of Drugs in Tissues (Organized in Cooperation with International Society of Anti-Infective Pharmacology D. R. Andes: Consultant: Astellas, Actelion, Roche, Theravance, Zavante, (ISAP)) Scynexis, Melinta. A. Andrémont: Da Volterra, Consultant, Scientific Advisor (Review Panel or Antimicrobial Resistance Control: A One-Health Approach Advisory Committee). Carbapenemases D. Andreotti, None. A. Felici, None. M. Negri, None. C. Napolitano, None. Surveillance for the 21st Century A. Anyamba, None. C. A. Arias, Theravance, Bayer, Merck, Novartis, Pfizer. Consultant. Antimicrobial Resistance among Gram-Positive Bacterial Pathogens: Theravance, Merck, Actavis. Grant Investigator. Pfizer, Theravance, The Continuous and Emerging Challenges, Mechanisms and Epidemiology Medecins Company, Actavis, Bayer, Novartis. Speaker's Bureau. Crossing the Diagnostic Divide: The Ongoing Evolution of the Revolution in Clinical and Public Health Microbiology G. Armstrong, None. Antimicrobial Research Award Lecture: Quinolone and Multidrug Resistance - A Formidable Foe D. M. Aronoff, Summit Pharmaceuticals. Consultant. Maurice Hilleman Award Lecture: Towards a Universal Influenza Virus Vaccine D. M. Aronoff, Summit Pharmaceuticals. Consultant. ICAAC Lecture: Clean Hands Save Lives: Worldwide Perspectives D. M. Aronoff, Summit Pharmaceuticals. Consultant. J. R. Arribas, Consultant. Janssen Cilag Consultant. Abbvie Consultant. BMS Consultant. Gilead. Consultant. MSD. Consultant. Viiv, Grant Investigator. Janssen Cilag, Grant Investigator. Abbvie, Grant Investigator. BMS, Grant Treatment of HIV Infection Investigator. Gilead, Grant Investigator. MSD, Grant Investigator. Microbiology Research Funding Opportunities R. M. Atlas, None. We Are Not Alone: Emerging Issues of the Human Mycobiome (Organized in Cooperation with the lmmunocompromised Host Society [ICHS]) T. Auchtung, None. Establishing and Working in a Start-up Environment A. August, None. New Frontiers in HIV Cure B. Autran, Grant from Janssen, Grant Investigator. Infectious Diseases Treatment Guidelines and Beyond: Where Do We Stand in 2016? P. Auwaerter, medical-legal expert testimony. P. Auwaerter, medical-legal Lyme Disease 2016 Update expert testimony Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance A.N.G. Dabul, None. J.S. Avaca-Crusca, None. D.V. Tyne, None. M.S. Gilmore, in Gram-positive Bacteria None. I.L.B.C. Camargo, None. Infectious Disease Quiz R. K. Avery, Shire, Merck, Chimerix, Astellas. Investigator. Challenges of Infections in Lung Transplantation R. K. Avery, Shire, Merck, Chimerix, Astellas. Investigator. Emerging Technologies and Biomarkers for Fungal Diagnostics E. N. Babady, None. On Your Bench, Get Set, Go! Practical Updates for the Clinical Microbiologist E. N. Babady, None. Microbe 2016 Disclosures Listed by Session A. Babosan, None. F. Lebreton, None. C. de Champs, None. G. Pier, None. D. RNA Modulation and Cellular Signals in Antimicrobial Resistance Skurnik, None. T. Guillard, None. Microbiology Career Choices: What's Available and How to Succeed N. Baker, None. J. Balada-Llasat, Biomerieux, Scientific Advisor (Review Panel or Advisory Error Rates in Clinical Microbiology Laboratories: Where Do We stand? Committee). Emerging Technologies and Biomarkers for Fungal Diagnostics N. Banaei, None. Optimal Use of Rapid Diagnostics in the Clinical Microbiology Laboratory for Quality Improvement and Clinical Care R. Banerjee, None. Pixels, Paints, and Pop Culture: Unique Perspectives on Science Communication M. Banks, None. At the Intersection of Art and Microbiology M. Banks, None. Practical Advice for Lab Management: CPT Codes, Compliance, Reimbursement, and LOINC Codes P. Banning, None. Aiming at Non-Conventional Approaches to TB Therapies (Supported Jointly by the Bill & Melinda Gates Foundation) A. K. Barczak, None. Practical Considerations and Novel Applications of MALDI-TOF MS in the Clinical Laboratory A. P. Barker, None. Case Management of Tropical Infectious Diseases and Travel Medicine (Organized in Cooperation with the American Society of Tropical E. D. Barnett, PaxVax, Investigator. PaxVax, Scientific Advisor (Review Panel Medicine and Hygiene (ASTMH)) or Advisory Committee). New Frontiers in HIV Cure D. Barouch, None. Forty Years after the Double Bind H. A. Barton, None. Practical Advice for Lab Management: CPT Codes, Compliance, Reimbursement, and LOINC Codes V. S. Baselski, None. Late Breaking Clinical Microbiology Updates from Laboratory Practices and Professional Affairs Committee V. S. Baselski, None. S.A. Becka, None. J.A. Gatta, None. E.T. Zeiser, None. J.J. LiPuma: Grant Investigator; AstraZeneca, Actavis. K.M. Papp-Wallace: Grant Investigator; RNA Modulation and Cellular Signals in Antimicrobial Resistance AstraZeneca, Actavis, Merck, Wockhardt. Foundations to Frontiers: The Molecular Revolution J. Beckwith, None. K. Begins: Employee; Green Mountain Antibodies. A. Maddur, None. W. Staphylococcus aureus Infection Treatments: New Compounds, New Church: Employee; Green Mountain Antibodies. P. Panizzi: None. P. Bock: Strategies None. Engaging and Inclusive Teaching in the Microbial Sciences G. S. Begley, None. Novel Insights Regarding the Microbiome and Pregnancy (Organized in Cooperation with the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG)) R. Beigi, None. Lyme Disease 2016 Update J. T. Belisle, None. F. Bellissimo-Rodrigues: None. H. Soule: None. D. Pires: None. A. Gayet- Hand Hygiene and Environmental Issues in the Healthcare Setting Ageron: None. D. Pittet: None. Clinical Virology L.A. Beltz: None. B. Beovic, MSD, unrestricted grant to University for my research. Grant Investigator. Rempex, country principal investigator in a multicentre study. Investigator. Astellas, Astra Zeneca, Pfizer, MSD,